[Lecture and Event Report] “Femtech Fes! 2021 – Three Days That Will Transform Your Taboo Into a Heart-Pounding Thrill,” Co-hosted by fermata and HGPI (October 22 to 24, 2021)
date : 12/16/2021
Tags: Women's Health
![[Lecture and Event Report] “Femtech Fes! 2021 – Three Days That Will Transform Your Taboo Into a Heart-Pounding Thrill,” Co-hosted by fermata and HGPI (October 22 to 24, 2021)](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/DSC6496.jpg)
Health and Global Policy Institute (HGPI) and fermata co-hosted “Femtech Fes! 2021 – Three Days That Will Transform Your Taboo Into a Heart-Pounding Thrill.” HGPI Manager Ms. Yuko Imamura served as moderator for a panel discussion on the first day of the event.
Session title
“Examining Femtech in the Context of the PMD Act and Its Future Prospects From the Perspective of Government Agencies and Trade Associations”
Session participants
Speakers
Madoka Murakami (Innovative Products Reviewer, Medical Device Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare)
Ryutaro Iida (Division Manager, Sakura Global Holding Co., Ltd.)
Moderator
Yuko Imamura (Manager, HGPI)
For fermata’s report on the event, please visit the following link. Please note that the report is only available in Japanese.
https://hellofermata.com/blogs/news/reportfes2021
Top Research & Recommendations Posts
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] 2017 Public Survey on Healthcare in Japan
- [Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) (November 26, 2021)